1
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Ovarian Carcinoma: The Physician's Obligation to Improve Prognosis

Pages 433-437 | Published online: 18 Apr 2016

REFERENCES

  • Abel, S.: Ovarian carcinoma; diagnosis and treatment. Missouri Med. 54: 423–429, 1957.
  • Latour, J. P. A. and Davis, B. A.: A critical assessment of the value of x-ray therapy in primary ovarian carcinoma. Am. J. Obst. & Gynec. 74: 968–976, 1957.
  • Mengert, W. F.: Carcinoma of the ovary. South. M. J. 47: 918–922, 1954.
  • Javert, C. T. and Rascoe, R. R.: Serous cystadenocarcinoma of the ovary; a review of 127 cases. S. Clin. North America 33: 557–584, 1953.
  • Krohn, L, Jaffe, H. L. and Izenstark, J. L.: Postoperative radiation therapy for ovarian cancer; indications for newer types of irradiation. Obst & Gynec. 9: 111–122, 1957.
  • Turner, J. C., jr., ReMine, W. H. and Dockerty, M. B.: A clinicopathologic study of 172 patients with primary carcinoma of the ovary. Surg. Gynec. & Obst. 109: 198–206, 1959.
  • Howson, J. Y. and Montgomery, T. L.: An attack upon the delay period in diagnosis of pelvic cancer. Am. J. Obst. & Gynec. 57: 1098–1106, 1949.
  • Hesseltine, H. G and Smith, R. L: Ovarian malignancy. Am. J. Obst. & Gynec. 72: 1326 1334, 1956.
  • Henderson, D. N. and Bean, J. L.: Results of treatment of primary ovarian malignancy. Am. J. Obst. & Gynec. 73: 657–663, 1957.
  • Randall, J. H.: Treatment of ovarian carcinoma; evaluation of results at State University of Iowa Hospitals. Obst. & Gynec. 5: 445–451, 1955.
  • Hollenbeck, Z. J.: Ovarian cancer; prophylactic oophorectomy. Am. Surgeon 21: 442–446, 1955.
  • Carlin, G. J. and Frodey, R. J.: Primary ovarian carcinoma. Obst. & Gynec. 9: 71–76, 1957.
  • Randall, C. L.: Treatment of ovarian cancer. New York J. Med. 55: 3299–3301, 1955.
  • Munnell, E. W., Jacox, H. W. and Taylor, H. C., jr.: Treatment and prognosis in cancer of the ovary. Am. J. Obst. & Gynec. 74: 1187–1200, 1957.
  • Taylor, H. C., jr. and Long, M. E.: Problems of cellular and tissue differentiation in papillary adenocarcinoma of the ovary. Am. J. Obst. & Gynec. 70: 753–765, 1955.
  • Davis, B. A., Latour, J. P. A. and Philpott, N. W.: Primary carcinoma of ovary. Surg. Gynec. & Obst. 102: 565–573, 1956.
  • Alha, A. L. and Merenmies, L.: Carcinoma of ovary; 286 cases treated at Women's Clinic, University of Helsinki, 1934–1948. Ann. chir. et gynaec. Fenniae 44: 157–169, 1955.
  • Vlad, V., Hanutin, M. and Angeleson, V.: La tumeur thécale de l'ovaire. Gynéc. et obst. 56: 353–364, 1957.
  • Howson, J. Y.: Treatment of pelvic cancer in Philadelphia. Obst. & Gynec. 4: 591–597, 1954.
  • Chu, F. C.: The results of treatment of ovarian cancer with one million volt x-ray. Surg. Gynec. & Obst. 104: 45–52, 1957.
  • Weed, J. C. and Barraza, D. F.: Management of ovarian carcinoma in 123 patients: With particular emphasis on the prophylactic use of radioactive gold. South. M. J. 52: 278–282, 1959.
  • Smith, G. V.: Ovarian tumors with special reference to some unexpectedly good outcomes in treatment of cancer of the ovary. Am. J. Surg. 95: 336–340, 1958.
  • Keettel, W. C. and Elkins, H. B.: Experience with radioactive colloidal gold in treatment of ovarian carcinoma. Am. J. Obst. & Gynec. 71: 553–568, 1956.
  • Cohen, J. S. and Sklaroff, D. M.: Intraperitoneal radioactive gold in ovarian cancer. Obst. & Gynec. 6: 68–74, 1955.
  • Kepp, R. L., Hartl, H. and Müller, K.: Die Bedeutung von Radiogold 198 für die gynäkologische Strahlentherapie. Deutsche med. Wchnschr. 80: 19–21, 1955.
  • Sykes, M. P., Rundles, R. W., Pierce, V. K. and Karnofsky, D. A.: Triethylene melamine in management of far advanced ovarian cancer. Surg. Gynec. & Obst. 101: 133–140, 1955.
  • Bateman, J. C. and Winship, T.: Palliation of ovarian carcinoma with phosphoramide drugs. Surg. Gynec. & Obst. 102: 347–354, 1956.
  • Bateman, J. C.: Chemotherapeutic management of advanced ovarian carcinoma. M. Ann. District of Columbia 28: 537–544, 1959.
  • Masterson, J. G., Calame, R. J. and Nelson, J.: A clinical study on the use of chlorambucil in the treatment of cancer of the ovary. Am. J. Obst. & Gynec. 79: 1002–1007, 1960.
  • Coggins, P., Eisman, S. H. and Ravdin, R.: Clinical evaluation of a new alkylating agent: Cytoxan (cyclophosphamide). Cancer 13: 1254–1260, 1960.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.